Merck
Merck & Co Inc is an American biopharmaceutical corporation engaged in the discovery, development, manufacture, and marketing of human prescription medicines and vaccines. The company structures its operations into two main reportable segments: Pharmaceutical and Animal Health. Its Human Health pharmaceutical portfolio includes oncology treatments such as Keytruda, diabetes treatments, cardiovascular therapies, and human vaccines like Gardasil. Principal revenue drivers are worldwide sales of proprietary prescription biopharmaceuticals and vaccines to healthcare wholesalers, hospitals, and government health agencies. The enterprise maintains a market-leading position within immuno-oncology and global pharmaceutical manufacturing based on commercial revenues. Merck is headquartered in Rahway, New Jersey, and its common stock is publicly traded on the New York Stock Exchange under ticker symbol MRK.
89 of the funds FundTelligence covers report a position in Merck.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 89
Funds holding Merck
- SEB Läkemedelsfond — SEB · 7.69 % (full portfolio disclosed, June 2026)
- Handelsbanken Helse Tema — Handelsbanken · 5.1 % (full portfolio disclosed, October 2026)
- Nordea North American Dividend — Nordea Funds · 3.58 % (full portfolio disclosed, September 2026)
- BlackRock iShares MSCI World Health Care Sector ESG UCITS ETF — BlackRock · 3.42 % (full portfolio disclosed, October 2026)
- Danske Invest Global Sustainable Future — Danske Invest · 2.79 % (full portfolio disclosed, September 2026)
- Nordea Global Social Empowerment — Nordea Funds · 2.67 % (full portfolio disclosed, September 2026)
- Franklin Mutual Global Discovery Fund — Franklin Templeton · 2.47 % (full portfolio disclosed, September 2026)
- Nordea US Equity Portfolio Base — Nordea Funds · 2.37 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 89 funds holding it.